“…Studies addressing behavioral and/or neurological abnormalities induced by T. gondii infection utilized various experimental paradigms, including intraperitoneal (e.g., [7], [9], [10], [21], [31], [32], [48], [49]), subcutaneous (e.g., [17], [29], [30]) or peroral (present study, [6], [19], [20], [25], [45], [50]) administration of various parasite doses and congenital T. gondii infection [18], [23], [51], [52].…”